Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Apr;11(4):e484-e485.
doi: 10.1016/S2214-109X(23)00123-7.

Planning to introduce novel tuberculosis vaccines in high burden settings: how could this be done?

Affiliations
Comment

Planning to introduce novel tuberculosis vaccines in high burden settings: how could this be done?

Mark F Cotton et al. Lancet Glob Health. 2023 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

MFC reports payment from Vakzine Project Management and the Serum Institute of India to his institution as an investigator for the VPM1002 infant trials and from Biofabri to his institution as an investigator for the MTBVAC infant trials, in addition to financial support from Biofabri for attending the start up meetings for both trials. HR reports membership on the MTBVAC study team, and membership on Data Safety Monitoring Boards for the EMPIRICAL study and on steering committee for the TB Speed study, and membership of the FAMCRU board (but receiving no payment for any of these roles).

Comment on

References

    1. WHO . World Health Organization; Geneva: 2008. Global tuberculosis control: surveillance, planning, financing: WHO report 2008.
    1. WHO. UNAIDS . World Health Organization; Geneva: 2015. Global AIDS response progress reporting.
    1. WHO . World Health Organization; Geneva: 2018. WHO preferred product characteristics for new tuberculosis vaccines.
    1. Nemes E, Geldenhuys H, Rozot V, et al. Prevention of M tuberculosis infection with H4:IC31 vaccine or BCG revaccination. N Engl J Med. 2018;379:138–149. - PMC - PubMed
    1. Tait DR, Hatherill M, Van Der Meeren O, et al. Final analysis of a trial of M72/AS01E vaccine to prevent tuberculosis. N Engl J Med. 2019;381:2429–2439. - PubMed

MeSH terms

Substances